Mereo BioPharma Group plc
A clinical-stage biopharma developing and commercializing novel therapies for rare diseases.
MREO | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- ONE CAVENDISH PLACE, LONDON
- Website:
- https://www.mereobiopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company founded in 2015. The company is dedicated to improving the lives of patients by developing and commercializing novel therapies for rare diseases. Its strategy focuses on identifying and advancing treatments with significant unrealized, long-term potential. Mereo's clinical pipeline includes key product candidates such as setrusumab for osteogenesis imperfecta (OI) and alvelestat. The company actively collaborates with partners, patient communities, and healthcare professionals to progress its therapeutic programs and address significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Mereo BioPharma Group plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mereo BioPharma Group plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mereo BioPharma Group plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
